Robert S. Fishman, Chief Medical Officer at CORCEPT THERAPEUTICS INC (CORT), sold 16,000 shares at $16.22 ($260K) on 2018-04-06, disclosed to the SEC on 2018-04-09.
Open-market sale of $260k CORT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.22 | 8,000 | $130K | 50.0% |
| 2 | $16.22 | 8,000 | $130K | 50.0% |
| Total | $16.22 avg | 16,000 | $260K | 100% |
| Filing → |
| CORT | SELL | 2018-09-11 | $117K | — | Filing → |
| CORT | SELL | 2018-08-08 | $113K | — | Filing → |
| CORT | SELL | 2018-07-09 | $121K | — | Filing → |